Usefulness of Low-dose Methotrexate Monotherapy for Treating Sarcoidosis

Abstract

Although the efficacy of low-dose MTX monotherapy for sarcoidosis in this study was not high (23%), some patients exhibited definite improvements, and the drug proved to be safe, suggesting its possible benefits as a single agent for treating sarcoidosis.